Los Angeles, California–(Newsfile Corp. – November 14, 2024) – OG DNA Genetics Inc. (the “Corporation“) announced today that it is varying the terms of its existing substantial issuer bid (the “Offer“) in order to extend the expiry date of the Offer to 5:00 p.m. (Toronto time) on December 2, 2024, or such later date and […]